GPR32 antibody
GTX71225
ApplicationsFlow Cytometry, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
Product group Antibodies
TargetGPR32
Overview
- SupplierGeneTex
- Product NameGPR32 antibody
- Delivery Days Customer9
- Application Supplier NoteIHC-P: 38 microg/ml. IHC-P: 38 microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsFlow Cytometry, Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID2854
- Target nameGPR32
- Target descriptionG protein-coupled receptor 32
- Target synonymsDRV1, RVDR1, probable G-protein coupled receptor 32, resolvin D1 receptor
- HostRabbit
- IsotypeIgG
- Protein IDO75388
- Protein NameProbable G-protein coupled receptor 32
- Scientific DescriptionThis gene is intronless and encodes a member of the G-protein coupled receptor 1 family. The encoded protein binds to resolvin D1 and lipoxin A4 and has been linked to pulmonary inflammation. A related pseudogene has been identified on chromosome 19. [provided by RefSeq, Nov 2012]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Wang L, Choi HS, Su Y, et al. Protective effect of 17S‑epoxy‑docosapentaenoic acid against dextran sulfate sodium induced ulcerative colitis in BALB/c mice. Mol Med Rep. 2022,26(3):pii: 278. doi: 10.3892/mmr.2022.12794.Read this paper
- Chiurchiù V, Leuti A, Saracini S, et al. Resolution of inflammation is altered in chronic heart failure and entails a dysfunctional responsiveness of T lymphocytes. FASEB J. 2019,33(1):909-916. doi: 10.1096/fj.201801017RRead this paper
- Chattopadhyay R, Mani AM, Singh NK, et al. Resolvin D1 blocks H(2)O(2)-mediated inhibitory crosstalk between SHP2 and PP2A and suppresses endothelial-monocyte interactions. Free Radic Biol Med. 2018,117:119-131. doi: 10.1016/j.freeradbiomed.2018.01.034Read this paper
- Sulciner ML, Serhan CN, Gilligan MM, et al. Resolvins suppress tumor growth and enhance cancer therapy. J Exp Med. 2018,215(1):115-140. doi: 10.1084/jem.20170681Read this paper
- Chattopadhyay R, Raghavan S, Rao GN. Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function. Redox Biol. 2017,12:438-455. doi: 10.1016/j.redox.2017.02.023Read this paper
- Chiurchiù V, Leuti A, Dalli J, et al. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses. Sci Transl Med. 2016,8(353):353ra111. doi: 10.1126/scitranslmed.aaf7483Read this paper
- Croasdell A, Thatcher TH, Kottmann RM, et al. Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages. Am J Physiol Lung Cell Mol Physiol. 2015,309(8):L888-901. doi: 10.1152/ajplung.00125.2015Read this paper
- Hsiao HM, Thatcher TH, Levy EP, et al. Resolvin D1 attenuates polyinosinic-polycytidylic acid-induced inflammatory signaling in human airway epithelial cells via TAK1. J Immunol. 2014,193(10):4980-7. doi: 10.4049/jimmunol.1400313Read this paper
- Norling LV, Dalli J, Flower RJ, et al. Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. Arterioscler Thromb Vasc Biol. 2012,32(8):1970-8. doi: 10.1161/ATVBAHA.112.249508Read this paper
- Dartt DA, Hodges RR, Li D, et al. Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. J Immunol. 2011,186(7):4455-66. doi: 10.4049/jimmunol.1000833Read this paper

